NASDAQ:EGLT - Egalet Stock Price, News, & Analysis

0.00 (0.00 %)
(As of 06/18/2019 04:00 PM ET)
Today's Range
Now: $0.3273
50-Day Range
MA: $0.25
52-Week Range
Now: $0.3273
Average Volume853,425 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Egalet Corporation, a specialty pharmaceutical company, develops, manufactures, and commercializes treatments for patients with pain and other conditions. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate; and ARYMO ER, an extended-release (ER) morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:EGLT



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A

Receive EGLT News and Ratings via Email

Sign-up to receive the latest news and ratings for EGLT and its competitors with MarketBeat's FREE daily newsletter.

Egalet (NASDAQ:EGLT) Frequently Asked Questions

What is Egalet's stock symbol?

Egalet trades on the NASDAQ under the ticker symbol "EGLT."

How were Egalet's earnings last quarter?

Egalet (NASDAQ:EGLT) released its earnings results on Wednesday, August, 8th. The specialty pharmaceutical company reported ($0.22) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.28) by $0.06. The specialty pharmaceutical company had revenue of $7.44 million for the quarter, compared to analysts' expectations of $8.64 million. View Egalet's Earnings History.

What price target have analysts set for EGLT?

1 Wall Street analysts have issued 1 year price objectives for Egalet's stock. Their predictions range from $1.50 to $1.50. On average, they expect Egalet's stock price to reach $1.50 in the next year. This suggests a possible upside of 358.3% from the stock's current price. View Analyst Price Targets for Egalet.

What is the consensus analysts' recommendation for Egalet?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Egalet in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Egalet.

Has Egalet been receiving favorable news coverage?

Headlines about EGLT stock have trended very negative on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Egalet earned a coverage optimism score of -3.5 on InfoTrie's scale. They also gave media coverage about the specialty pharmaceutical company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an impact on the company's share price in the near future. View News Stories for Egalet.

Who are some of Egalet's key competitors?

What other stocks do shareholders of Egalet own?

Who are Egalet's key executives?

Egalet's management team includes the folowing people:
  • Mr. Robert S. Radie, Pres, CEO & Director (Age 55)
  • Mr. Stanley J. Musial, Exec. VP, CFO & Sec. (Age 57)
  • Dr. Mark Strobeck, Exec. VP & COO (Age 47)
  • Ms. Barbara A. Carlin, Sr. VP & Chief Accounting Officer (Age 43)
  • Dr. Karsten Lindhardt M.Sc., Ph.D., Chief Scientific Officer (Age 46)

How do I buy shares of Egalet?

Shares of EGLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Egalet's stock price today?

One share of EGLT stock can currently be purchased for approximately $0.3273.

What is Egalet's official website?

The official website for Egalet is

How can I contact Egalet?

Egalet's mailing address is 600 LEE ROAD SUITE 100, WAYNE PA, 19087. The specialty pharmaceutical company can be reached via phone at 610-833-4200 or via email at [email protected]

MarketBeat Community Rating for Egalet (NASDAQ EGLT)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  350 (Vote Outperform)
Underperform Votes:  228 (Vote Underperform)
Total Votes:  578
MarketBeat's community ratings are surveys of what our community members think about Egalet and other stocks. Vote "Outperform" if you believe EGLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EGLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2019 by Staff

Featured Article: What is Call Option Volume?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel